NorthWest Biotherapeutics Inc (NWBO)

[john1045]

Great find and amazed at the following two paragraphs in this document and people think this is not going on in the market.

30. An example of this occurred between April 16, 2012 and April 18, 2012, when thesecurity price for SNPK ranged from approximately $0.73 to $2.40. During that time, WDCO frequently adjusted its bid so that it stayed within approximately $0.19 of the best bid for the
security. However, it maintained a static offer of approximately $2.69 throughout the entire period which ranged from approximately $0.29 to $1.95 away from the best offer. During that time, WDCO effected short sales for approximately 14.0 million shares of SNPK, none of which were
executed at or near the price of its posted offer. These short sales ranged in prices from approximately $0.30 to $1.80 below WDCO’s posted offer of approximately $2.69.

31. While trading this security, WDCO effected many short sales, selling short approximately 155 million shares of SNPK (in contrast to disproportionately selling long approximately 17 million shares) and making more than $3 million on those short sales.

32. Most of this trading did not constitute bona fide market making under Regulation SHO, and therefore WDCO improperly used the Regulation SHO exception to the locate requirement.